Antifungal Textile Treatments
category
Antifungal textile treatments target fungi (Trichophyton, Aspergillus, Candida) and mold (Cladosporium, Penicillium) using zinc pyrithione (ZPT, 0.3–1.0% owf), undecylenic acid derivatives (0.5–2.0% owf), copper compounds (Cu²⁺ at 50–500 ppm), or organic biocides (propiconazole, tebuconazole at 0.2–1.0% owf). Antifungal efficacy is tested per ISO 13629 (quantitative method) targeting >3 log reduction against Trichophyton mentagrophytes (athlete's foot pathogen) and ISO 16187 for mold resistance. Antifungal socks and insoles address the 15–25% adult population suffering from tinea pedis. Healthcare bedding and curtain applications target nosocomial fungal infections. Market exceeds $280 million for antifungal textile treatments globally.
Role
Essential treatment for footwear textiles, diabetic wound dressings, and immunocompromised patient bedding where fungal infection risk is clinically significant, reducing tinea pedis incidence and hospital-acquired fungal infection rates.